Sign Up to like & get
recommendations!
0
Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.2622
Abstract: The 60th American Society of Hematology (ASH) held in San Diego in December 2018 was followed by the 13th PostâASH chronic myeloproliferative neoplasms (MPNs) workshop on December 4 and 5, 2018. This closed annual workshop,…
read more here.
Keywords:
translational science;
chronic myeloproliferative;
treatment;
myeloproliferative neoplasms ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2022.2039117
Abstract: Patients with BCR-ABL negative chronic myeloproliferative neoplasms (MPNs) present with chronic kidney disease (CKD) in up to one third of cases. These patients are known to have increased cardiovascular risk and usually present with features…
read more here.
Keywords:
associated chronic;
disease;
renal disease;
myeloproliferative neoplasms ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.17130
Abstract: The effects of smoking on the molecular response (MR) and overall survival (OS) in patients with chronic myeloproliferative neoplasms (MPNs) have not been investigated before. We analysed a historical cohort of 498 consecutive patients diagnosed…
read more here.
Keywords:
chronic myeloproliferative;
molecular response;
survival patients;
patients chronic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Therapeutic Advances in Hematology"
DOI: 10.1177/20406207231154706
Abstract: Background: Patients with Philadelphia-negative chronic myeloproliferative neoplasms (MPN) typically incur high rates of infections and both drugs and comorbidities may modulate infection risk. Objectives: The present study aims to assess the effect of immunosuppressive agents…
read more here.
Keywords:
infection;
immunosuppressive therapies;
covid;
registry ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10112892
Abstract: Disease- and treatment-mediated immunodeficiency might render SARS-CoV-2 vaccines less effective in patients with hematologic diseases. We performed a prospective non-interventional study to evaluate humoral response after one and two doses of mRNA-1273, BNT162b2, or ChAdOx1…
read more here.
Keywords:
non myelofibrosis;
hematologic diseases;
sars cov;
chronic myeloproliferative ... See more keywords